Trials / Completed
CompletedNCT05743192
Discontinuation of Antibiotic Susceptibility Testing on Enterococcus Faecalis Positive Urine Cultures in Hospitalized Patients: an Impact on Antibiotic Prescriptions? (FaecaCible)
Discontinuation of Antibiotic Susceptibility Testing on Monobacterial Enterococcus Faecalis Positive Urine Cultures: an Impact on Antibiotic Prescriptions?
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 217 (actual)
- Sponsor
- Central Hospital, Nancy, France · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the study is to evaluate the impact of not reporting antibiotic susceptibility tests on antibiotic consumption for Enterococcus faecalis positive urine cultures in adult hospitalized patients. The secondary objectives are to evaluate the impact of this intervention on antibiotic prescription rates as well as on antibiotic consumption according to: patient gender, type of antibiotic therapy (probabilistic/documented) and diagnosis (urinary tract infection or colonization). It is hypothesized that antibiotic consumption is lower after the application of the absence of antibiotic susceptibility reporting compared to before.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Stop performing an antibiotic susceptibility test | Intervention = Stop performing an antibiotic susceptibility test for enterococcus faecalis in urine cultures. It defines two groups : one before and one after the intervention |
Timeline
- Start date
- 2023-02-15
- Primary completion
- 2023-06-08
- Completion
- 2023-06-08
- First posted
- 2023-02-24
- Last updated
- 2023-06-15
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05743192. Inclusion in this directory is not an endorsement.